SUDO-286 / Sudo Biosci - LARVOL DELTA

Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M (Businesswire) - "Sudo Biosciences...today announced that during January 2024, it completed a second close of its Series B financing, raising an additional $30 million from new investors Dementia Discovery Fund (DDF, a SV Health Investors Fund), Leaps by Bayer, and UPMC Enterprises, the innovation, commercialization and venture capital arm of UPMC. This brings the total raised in this upsized round to $147 million....Proceeds from the Series B fundraise will be used to advance two investigational TYK2 candidates into the clinic this year."

Financing • Immunology